Dr Constante U Abaya, MD | |
1200 N Ventura Rd, # C, Oxnard, CA 93030 | |
(805) 983-0730 | |
(805) 485-4586 |
Full Name | Dr Constante U Abaya |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 1200 N Ventura Rd, Oxnard, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003918459 | NPI | - | NPPES |
00A244540 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | A24454 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Constante U Abaya, MD 1200 N Ventura Rd, # C, Oxnard, CA 93030 Ph: (805) 983-0730 | Dr Constante U Abaya, MD 1200 N Ventura Rd, # C, Oxnard, CA 93030 Ph: (805) 983-0730 |
News Archive
Necrotizing enterocolitis (NEC) is a life-threatening intestinal disease of prematurity. Characterized by sudden and progressive intestinal inflammation and tissue death, it affects up to 11,000 premature infants in the United States annually, and 15-30% of affected babies die from NEC.
Building on the success of innovative research by the PRISM project, the Innovative Medicine Initiative 2, a joint undertaking between the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA), has backed the program with funding for a new project to explore the underlying biology of Alzheimer's disease, schizophrenia and Major Depressive Disorder (MDD).
Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2010.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that two oral podium presentations on the company's lead candidate, PRX302, will be made at the 2010 Annual Meeting of the American Urological Association (AUA). These presentations will include six month data from the Phase 2b clinical study of PRX302 called TRIUMPH, in patients with moderate to severe benign prostatic hyperplasia (BPH).
› Verified 5 days ago
John R Walters, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 703 N A St, Oxnard, CA 93030 Phone: 805-485-2340 Fax: 805-485-1429 | |
Dr. Donald Miller, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2241 Wankel Way Ste A, Oxnard, CA 93030 Phone: 805-983-0521 Fax: 805-919-2684 | |
Victor H Alcocer, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1901 Outlet Center Dr Ste 200, Oxnard, CA 93036 Phone: 805-981-8300 Fax: 805-981-8302 | |
Dr. Jack Shenouda, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1600 N Rose Ave, Oxnard, CA 93030 Phone: 717-577-3938 Fax: 785-354-6349 | |
Peter G Aline, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1901 Outlet Center Dr, #220, Oxnard, CA 93036 Phone: 805-988-4118 Fax: 805-988-1239 | |
Dr. Romany F. Demian, M.D. Gastroenterology Medicare: May Accept Medicare Assignments Practice Location: 971 W 7th St # B, Suite # B, Oxnard, CA 93030 Phone: 805-483-2500 Fax: 805-483-2525 |